A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
Clinical trial NCT07100418 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07100418
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2026-09-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.